|
| 37137584 | Activation of skeletal muscle FAPs by LPA requires the Hippo signaling via the FAK pathway. | | 2023 |
| 36399263 | Extraction and Purification of Single Nuclei from Frozen Human Brain Tissue. | Methods in Molecular Biology | 2023 |
| 37645998 | Mapping Human Tissues with Highly Multiplexed RNA in situ Hybridization. | bioRxiv | 2023 |
| 37149155 | Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis. | | 2023 |
| 35094654 | S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction. | Adipocyte | 2022 |
| 35464399 | Lysophosphatidic Acid Receptor 3 Suppress Neutrophil Extracellular Traps Production and Thrombosis During Sepsis. | Frontiers in Immunology | 2022 |
| 36242998 | Somatic genomic mosaicism in the brain: Identified mutations provide challenges and opportunities for the clinic. | Med | 2022 |
| 35385768 | Activation of the ATX/LPA/LPARs axis induces a fibrotic response in skeletal muscle. | Matrix Biology | 2022 |
| 35948083 | Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA), UCM-14216, Ameliorates Spinal Cord Injury in Mice. | Journal of Medicinal Chemistry | 2022 |
| 36072569 | CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuries. | Frontiers in Cellular Neuroscience | 2022 |
| 35725892 | The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis. | CNS Drugs | 2022 |
| 35409312 | Sphingosine 1-Phosphate Receptor 5 (S1P) Knockout Ameliorates Adenine-Induced Nephropathy. | International Journal of Molecular Sciences | 2022 |
| 35406635 | Lysophosphatidic Acid Receptor 5 (LPA) Knockout Ameliorates the Neuroinflammatory Response In Vivo and Modifies the Inflammatory and Metabolic Landscape of Primary Microglia In Vitro. | Cells | 2022 |
| 35920162 | LPA Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction. | Circulation Research | 2022 |
| 35783097 | Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod. | Frontiers in Cellular Neuroscience | 2022 |
| 35319013 | Author Correction: Comparative cellular analysis of motor cortex in human, marmoset and mouse. | Nature | 2022 |
| 34986275 | Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P -selective modulation. | FASEB Journal | 2022 |
| 34677611 | Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes. | Journal of Experimental Medicine | 2022 |
| 35026421 | Pain-like behavior in the collagen antibody-induced arthritis model is regulated by lysophosphatidic acid and activation of satellite glia cells. | Brain, Behavior, and Immunity | 2022 |
| 35136060 | Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate. | Nature Communications | 2022 |
| 34529832 | THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors. | Br J Pharmacol | 2021 |
| 33853612 | Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding. | Lipids in Health and Disease | 2021 |
| 33792787 | GABAergic deficits in absence of LPA receptor, associated anxiety-like and coping behaviors, and amelioration by interneuron precursor transplants into the dorsal hippocampus. | Brain Structure and Function | 2021 |
| 33893167 | S1P-Gα Signaling Controls Astrocytic Glutamate Uptake and Mitochondrial Oxygen Consumption. | eNeuro | 2021 |
| 33841099 | Dual Role of Lysophosphatidic Acid Receptor 2 (LPA) in Amyotrophic Lateral Sclerosis. | Frontiers in Cellular Neuroscience | 2021 |
| 33510165 | LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesis. | Nature Communications | 2021 |
| 33925035 | A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis. | International Journal of Molecular Sciences | 2021 |
| 34356087 | Genomic Mosaicism Formed by Somatic Variation in the Aging and Diseased Brain. | Genes | 2021 |
| 33152386 | Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2021 |
| 33301355 | Endothelial S1P Signaling Counteracts Infarct Expansion in Ischemic Stroke. | Circulation Research | 2021 |
| 32974731 | Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis. | Molecular Neurobiology | 2021 |
| 33289881 | Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects. | Drugs | 2021 |
| 34795060 | Altered cell and RNA isoform diversity in aging Down syndrome brains. | Proceedings of the National Academy of Sciences of the United States of America | 2021 |
| 34618403 | Deletion of Sphingosine 1-Phosphate receptor 1 in cardiomyocytes during development leads to abnormal ventricular conduction and fibrosis. | Physiological Reports | 2021 |
| 34616062 | Comparative cellular analysis of motor cortex in human, marmoset and mouse. | Nature | 2021 |
| 34652685 | Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse Line. | Cell Biochemistry and Biophysics | 2021 |
| 32513900 | Unlabeled lysophosphatidic acid receptor binding in free solution as determined by a compensated interferometric reader. | J Lipid Res | 2020 |
| 32065590 | Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney. | J Clin Invest | 2020 |
| 32457796 | Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer's Disease. | Frontiers in Genetics | 2020 |
| 32330664 | Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification. | Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids | 2020 |
| 33317583 | Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells. | Molecular Brain | 2020 |
| 32929779 | Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain. | FASEB Journal | 2020 |
| 33042260 | LPA-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice. | Theranostics | 2020 |
| 32699111 | Brain cell somatic gene recombination and its phylogenetic foundations. | Journal of Biological Chemistry | 2020 |
| 31244601 | Effects of the LPA Receptor Deficiency and Stress on the Hippocampal LPA Species in Mice. | Frontiers in Molecular Neuroscience | 2019 |
| 31633020 | LPA overactivation induces neonatal posthemorrhagic hydrocephalus through ependymal loss and ciliary dysfunction. | Science advances | 2019 |
| 31607860 | CB and LPA Receptors Relationship in the Mouse Central Nervous System. | Frontiers in Molecular Neuroscience | 2019 |
| 32206173 | The Gene Conundrum in Alzheimer's Disease. | Cerebrum : the Dana forum on brain science | 2019 |
| 30550929 | Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice. | Brain, Behavior, and Immunity | 2019 |
| 30625282 | Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders. | Annual Review of Pharmacology and Toxicology | 2019 |